Healthcare CFOs spend more time dealing with cost management and, by extension, operational issues than any other single set of items on their to-do lists.

“Applause broke out in the OR. It was quite an amazing experience,” recalls Winfred Williams, MD, associate professor of medicine at MGH and Slayman’s nephrologist, referring to the moment the kidney “immediately pinked up” during implantation. 

“Surprisingly,” experts wrote in Nature Medicine, experience-based factors such as a physicians’ subspecialty or previous AI use failed to reliably predict the technology's impact. 

Buzzworthy developments of the past few days.

Imperfect algorithms. Resistant clinicians. Wary patients. Divisive disparities. The plot ingredients of a flashy techno-thriller coming to a cineplex near you? No—just a few of the many worries that provider organizations take on when they move to adopt AI at scale. 

Eric Secemsky, MD, from Beth Israel Deaconess Medical Center and Harvard Medical School, says a lack of hands-on training and reimbursement challenges are hindering the adoption of IVUS.

Black, Hispanic and Asian/Pacific Islander patients are significantly less likely to undergo an IR procedure for acute, pulmonary embolism. 

“ALPHV/BlackCat and their affiliates haven’t attacked Change Healthcare. This time, they’ve attacked our families.”